AIG
KZR

American International Group’s Kezar Life Sciences KZR Stock Holding History

American International Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,517
Closed -$31.7K – 1451
2024
Q1 		$31.7K Sell
3,517
-30
-0.8% -$273 ﹤0.01% 2873
2023
Q4 		$33.6K Sell
3,547
-15
-0.4% -$132 ﹤0.01% 2895
2023
Q3 		$42.4K Buy
3,562
+127
+4% +$2.25K ﹤0.01% 2856
2023
Q2 		$84.2K Buy
3,435
+894
+35% +$23.3K ﹤0.01% 2686
2023
Q1 		$79.5K Buy
2,541
+51
+2% +$2.95K ﹤0.01% 2556
2022
Q4 		$175K Sell
2,490
-9
-0.4% -$667 ﹤0.01% 2193
2022
Q3 		$215K Buy
2,499
+322
+15% +$31.3K ﹤0.01% 2112
2022
Q2 		$180K Buy
2,177
+297
+16% +$26.2K ﹤0.01% 2259
2022
Q1 		$312K Buy
1,880
+21
+1% +$3.01K ﹤0.01% 1984
2021
Q4 		$311K Sell
1,859
-14
-0.7% -$1.58K ﹤0.01% 2092
2021
Q3 		$162K Sell
1,873
-45
-2% -$2.98K ﹤0.01% 2556
2021
Q2 		$104 Buy
1,918
+94
+5% +$5.34K ﹤0.01% 2866
2021
Q1 		$109 Buy
1,824
+4
+0.2% +$234 ﹤0.01% 2671
2020
Q4 		$95 Sell
1,820
-52
-3% -$2.89K ﹤0.01% 2686
2020
Q3 		$91K Buy
1,872
+292
+18% +$14K ﹤0.01% 2578
2020
Q2 		$82K Sell
1,580
-255
-14% -$12.9K ﹤0.01% 2651
2020
Q1 		$80K Buy
1,835
+861
+88% +$35K ﹤0.01% 2443
2019
Q4 		$39K Sell
974
-8
-0.8% -$246 ﹤0.01% 2936
2019
Q3 		$32K Sell
982
-7
-0.7% -$338 ﹤0.01% 2976
2019
Q2 		$76K Buy
989
+186
+23% +$28.9K ﹤0.01% 2813
2019
Q1 		$142K Buy
803
+464
+137% +$91.4K ﹤0.01% 2408
2018
Q4 		$80K Sell
339
-3
-0.9% -$733 ﹤0.01% 2705
2018
Q3 		$73K Buy
+342
New +$59.7K ﹤0.01% 2959

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

American International Group's KZR Position: Q2 2024 in Review

American International Group sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 3,517 shares — an estimated $31.7K sold.

American International Group first reported a position in KZR in Q3 2018 and held it in 23 quarters. The position peaked at $312K in Q1 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • American International Group reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 3,517 Kezar Life Sciences shares in Q2 2024, an estimated $31.7K.
  • American International Group first reported a position in Kezar Life Sciences in Q3 2018 and held it in 23 quarters.
  • American International Group's Kezar Life Sciences position peaked at $312K in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.